31 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
27 Aug 20
Entry into a Material Definitive Agreement
9:30am
, packaging, labeling, quality assurance testing and release, shipping and storage of a product.
1.30 “MHLW”. MHLW means the Japanese Ministry of Health … a co-formulation or co-packaging of the Compound with an Other API for which Processa has not acquired (whether by acquisition or licensing) all
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
29 Oct 14
Entry into a Material Definitive Agreement
12:00am
the right to design and employ such promotional materials including, without limitation, any packaging, labeling, advertising. marketing, package
424B4
nfathro dm
5 Oct 20
Prospectus supplement with pricing info
4:16pm
8-K
EX-1.1
z67f17xl
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
8-K
EX-10.1
854v8djcks7
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.1
wdycq 96cvwna
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
8-K
EX-1.1
9ucma
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm